RDIF announces major Sputnik V efficacy data from San Marino, an upcoming registration of the Sputnik M vaccine and reiterates vaccine combos are the key to fight the pandemic

RDIF announces major Sputnik V efficacy data from San Marino, an upcoming registration of the Sputnik M vaccine and reiterates vaccine combos are the key to fight the pandemic ​​CEO of RDIF Kirill Dmitriev, Director of the Gamaleya Center Alexander Gintsburg and Deputy Director Denis Logunov participated in a global press-conference making several major announcements and taking questions from the media. RDIF announced the real-world data of the Ministry of Health of the Republic of San Marino on the Russian Sputnik V vaccine demonstrating it is 80% effective against coronavirus infection from 6th to 8th months after administering the second dose. https://ift.tt/eA8V8J